Self-organizing molecular field analysis: A tool for structure-activity studies

Journal of Medicinal Chemistry

Volumn 42, Issue 4, 1999, Pages 573-583

  Robinson, Daniel D ^a   Winn, Peter J ^a   Lyne, Paul D ^a   Richards, W Graham ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BINDING AFFINITY; BINDING SITE; CORRELATION FUNCTION; ELECTRICITY; MOLECULAR DYNAMICS; MOLECULAR MODEL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STEREOCHEMISTRY; STRUCTURE ANALYSIS;

DRUG DESIGN; ENDOTHELINS; MODELS, MOLECULAR; STEROIDS; STRUCTURE-ACTIVITY RELATIONSHIP; SULFONAMIDES; TRANSCORTIN;

EID: 0033602217     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9810607     Document Type: Article

References (57)

1. Hancsh, C.; Fujita, T. r-s-p analysis. A method for the correlation of biological activity and chemical structure. J. Am. Chem. Soc. 1964, 86, 1616-1626.
2. van de Waterbeemd, H. Advanced computer assisted techniques in drug discovery; VCH: Weinheim, 1995; Vol. 3.
3. van de Waterbeemd, H. Chemometric methods in molecular design; VCH: Weinheim, 1995; Vol. 2.
4. Kubinyi, H. 3D QSAR in drug design: theory, methods and applications; ESCOM Science Publishers B.V.: Leiden, The Netherlands, 1993; 3D QSAR in Drug Design: Ligand-Protein Interactions and Molecular Similarity; Kulwer Academic Publishers: Dordecht, The Netherlands, 1998; 3D QSAR in Drug Design: Recent Advances; Kulwer Academic Publishers: Dordecht, The Netherlands, 1998.
5. Cramer, R. D., III.; Patterson, D. E.; Bunce, J. D. Comparitive molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J. Am. Chem. Soc. 1988, 110, 5959-5967
6. Goodford, P. J. A computational procedure for determining energetically favorable binding sites on biologically important molecules. J. Med. Chem. 1985, 28, 849-857.
7. Dunn, W. J.; Wold, S.; Edlund, U.; Hellberg, S. Multivariate structure-activity relationships between data from a battery of biological tests and an ensemble of structure descriptors. Quant. Struct.-Act. Relat. 1984, 3, 131-137.
8. Baroni, M.; Clementi, S.; Cruciani, G.; Costantino, G.; Riganelli, P. Predictive ability of regression models part II: selection of the best predictive PLS model. J. Chemometr. 1992, 6, 347-356.
9. Good, A. C.; So, S.-S.; Richards, W. G. Structure-activity relationships from molecular similarity matrixes. J. Med. Chem. 1993, 36, 433-438.
10. Cruciani, G.; Watson, K. A.; Comparative molecular field analysis using GRID force-field and GOLPE variable selection methods in a study of inhibitors of glycogen phosphorylase b. J. Med. Chem. 1994, 37, 2589-2601.
11. Ortiz, A. R.; Pastor, M.; Palomer, A.; Cruciani, G.; Gago, F.; Wade, R. C. Reliability of comparative molecular field analysis models: effects of data scaling and variable selection using a set of human synovial fluid phospholipase A(2) inhibitors. J. Med. Chem. 1997, 40 (6), 1136-1148.
12. Baroni, M.; Costantino, G.; Cruciani, G.; Riganelli, D.; Valigi, R.; Clementi, S.; Generating optimal linear PLS estimations (GOLPE). An advanced chemometric tool for handling 3D-QSAR problems. Quant. Struct-Act. Relat. 1993, 12, 9-20.
13. Allen, M. S.; La Loggia, A. J.; Dorn, L. J.; Martin, M. J.; Costatino, G.; Hagen, T. J.; Koeheler, K. K.; Skolnick, P.; Cook, J. M. Predictive binding of β-Carboline Inverse Agonists and Antagonists via the CoMFA/GOLPE Approach. J. Med. Chem. 1992, 35, 4001-4010.
14. Cruciani, G.; Clementi, S.; Baroni, M. Variable Selection in PLS Analysis. In 3D QSAR in Drug Design; Kubinyi, H., Eds; ESCOM: Leiden, 1993; pp 551-564.
15. Good, A. C.; Peterson, S. J.; Richards, W. G. QSARs from similarity matrixes. Technique validation and application in the comparison of different similarity evaluation methods. J. Med Chem. 1993, 36, 2929-2937.
16. Cocchi, M.; Menziani, M. C.; De Benedetti, P. G. Use of advanced chemometric tools and comparison of different 3D descriptors in QSAR analysis of prazosin analogues alpha-1-adrenergic antagonists. In Trends in QSAR and Molecular Modelling 92; Wermuth, C. G., Ed.; ESCOM: Leiden, 1993; pp 527-529.
17. Tominaga, Y.; Fujiwara, I. Prediction-weighted partial least-squares regression method (PWPLS) 2: Application to CoMFA. J. Chem. Info. Comput. Sci. 1997, 37 (6), 1152-1157.
18. Pastor, M.; Cruciani, G.; Clementi, S.; Smart region definition: A new way to improve the predictive ability and interpretability of three-dimensional quantitative structure activity relation-ships. J. Med. Chem., 1997, 40 (10), 1455-1464.
19. Carbo, R.; Leyda, L.; Arnau, M. An electron density measure of the similarity between two compounds. Int. J. Quantum Chem. 1980, 17, 1185-1189.
20. Richards, W. G. In Modeling of biomolecular structures and mechanisms; Pullman, A., Jortner, A., Pullman, B., Eds.; Kluwer Academic Publishers: Dordrecht, The Netherlands, 1995; pp 365-369.
21. Dean, P. M. In 3D QSAR in drug design: theory, methods and applications; Kubinyi, H., Ed.; ESCOM Science Publishers B.V.: Leiden, The Netherlands, 1993; pp 150-172.
22. Hodgkin, E. E.; Richards, W. G. Molecular similarity based on electrostatic potential and electric field. Int. J. Quantum Chem., Quantum Biol. Symp. 1987, 14, 105-110.
23. Burt, G.; Huxley, P.; Richards, W. G. The Application of Molecular Similarity Calculations. J. Comput. Chem. 1990, 11, 1139-1146.
24. Seri-Levi, A.; Salter, R.; West, S.; Richards, W. G. Shape Similarly as a Single Independent Variable in QSAR. Eur. J. Med. Chem. 1994, 29, 687-694.
25. Montanari, C. A.; Tute, M. S.; Beezer, A. E.; Mitchell, J. C. Determination of receptor bound drug conformations by QSAR using flexible fitting to derive a molecular similarity index. J. Comput. Aid. Mol. Des. 1996, 10, 67-73.
26. Benigni, R.; Cotta Ramusino, M.; Giorgi, F.; Gallo, G. Molecular similarity matrixes and quantitative structure activity relationships: a case study with methodological implications. J. Med. Chem. 1995, 38, 629-635.
27. Horwell, D. C.; Howson, W.; Higginbottom, M.; Naylor, D.; Ratcliffe, G. S.; Williams, S. Quantitative structure activity relationships (QSARs) of N-terminus fragments of NK1 tachykinin antagonists: a comparison of classical QSARs and three-dimensional QSARs from similarity relationships. J. Med. Chem. 1995, 38, 4454-4462.
28. Free, S. M., Jr.; Wilson, J. W. A Mathematical Contribution to Structure-Activity Studies. J. Med. Chem. 1964, 7, 395-399.
29. Doweyko, A. M. The Hypothetical Active Site Lattice. An Approach to Modelling Active Sites from Data on Inhibitor Molecules. J. Med. Chem. 1988, 31, 1396-1406.
30. Doweyko, A. M.; Mattes, W. B. An application of 3D-QSAR to the analysis of the sequence specificity of DNA alkylation by uracil mustard. Biochemistry 1992, 31 (39), 9388-9392.
31. Doweyko, A. M. Three-Dimensional Pharmacophores from Binding Data. J. Med. Chem. 1994, 37, 1769-1778.
32. Kaminski, J. J.; Doweyko, A. M. Anti-ulcer agents. 6. Analysis of the in vitro biochemical and in vivo gastric antisecretory activity of substituted imidazol [1,2-a]pyridines and related analogues using comparative molecular field analysis and hypothetical active site lattice methodologies. J. Med. Chem. 1997, 40 (4), 427-436.
33. Manly, B. F. J. Multivariate Statistical Methods. A primer. Chapman and Hall: London, 1986.
34. Chatfield, C.; Collins, A. J. Introduction to Multivariate Analysis. Chapman and Hall: London, 1980.
35. Anzali, S.; Barnickel, G.; Krug, M.; Sadowski, J.; Wagener, M.; Gasteiger, J.; Polanski, J. The comparison of geometric and electronic properties of molecular surfaces by neural-networks: Application to the analysis of corticosteroid-binding globulin activity of steroids. J. Comput. Aid. Mol. Des. 1996, 10 (6), 521-534.
36. Jain, N. A.; Koile, K.; Chapman, D. COMPASS - Predicting Biological-Activities from Molecular-Surface Properties - Performance Comparisons on a steroid Benchmark. J. Med. Chem. 1994, 37, 2315-2327.
37. Tominaga, Y.; Fujiwara, I. Novel 3D descriptors using excluded volume: Application to 3D quantitative structure-activity relationships. J. Chem. Inf. Comput. Sci. 1997, 37 (6), 1158-1161.
38. Lobato, M.; Amat, L.; Besalu, E.; CarboDorca, R. Structure-activity relationships of a steroid family using quantum similarity measures and topological quantum similarity indices. Quant. Struct.-Act. Relat. 1997, 16 (6), 465-472.
39. Norinder, U. 3D-QSAR investigation of the Tripos benchmark steroids and some protein tyrosine-kinase inhibitors of styrene type using the TDQ approach. J. Chemometr. 1996, 10, 533-545.
40. Schnitker, J.; Gopalaswamy, R.; Crippen, G. M.; Objective models for steroid binding sites of human globulins. J. Comput. Aid. Mol. Des. 1997, 11 (1), 93-110.
41. Bravi, G.; Gancia, E.; Mascagni, P.; Pegna, M.; Todeschini, R.; Zaliani, A. MS-WHIM, New 3D Theoretical Descriptors Derived from Molecular Surface Properties: A Comparative 3D QSAR Study in a Series of Steroids. J. Comput.-Aid. Mol. Des. 1997, 11, 79-92.
42. Parretti, M. F.; Kroemer, R. T.; Rothman, J. H.; Richards, W. G.; Alignment of molecules by the Monte Carlo optimization of molecular similarity indices. J. Comput. Chem. 1997, 18 (11), 1344-1353.
43. Klebe, G.; Abraham, U.; Mietzer, T. Molecular Similarity Indexes in a Comparative-Analysis (COMSIA) of Drug Molecules to Correlate and Predict their Biological Activity. J. Med. Chem. 1994, 37, 4130.
44. Hahn, M.; Rogers, D. Receptor Surface Models. 2. Application to Quantitative Structure-Activity Relationships Studies. J. Med. Chem. 1995, 38, 2091-2102.
45. Wagener, M.; Sadowski, J.; Gasteiger, J. Autocorrelation of Molecular Surface Properties for Modelling Corticosteroid Binding Globulin and Cytosolic Ah Receptor Activity by Neural Networks. J. Am. Chem. Soc. 1995, 117, 7769-7775.
46. So, S.-S.; Karplus, M. Three-Dimensional Quantitative Structure-Activity Relationships from Molecular Similarity Matrixes and Genetic Neural Networks. 1. Method and Validations. J. Med. Chem. 1997, 40, 4347-4359.
47. Silverman, B. D.; Plat, D. E. Comparative Molecular Moment Analysis (CoMMA): 3D-QSAR without Molecular Superposition. J. Med. Chem. 1996, 39, 2129-2140.
48. Krystek, S. R.; Hunt, J. T.; Stein, P. D.; Stouch, T. R. Three-Dimensional Quantitative Structure-Activity Relationships of Sulfonamide Endothelin Inhibitors. Sulfonamide Endothelin Inhibitors. J. Med. Chem. 1995, 38, 659-668.
49. Dewar, M. J. S.; Zoebisch, E. G.; Healy, E. F.; Stewart, J. J. P.; A New General Purpose Quantum Mechanical Molecular Model. J. Am. Chem. Soc. 1985, 107, 3902.
50. Stewart, J. J. P. Mopac 6.0, Quantum Chemical Program Exchange, 455, 1990.
51. RATTLER, Oxford Molecular Ltd, Oxford, U.K.
52. Ferenzcy, G.; Reynolds, C. A.; Richards, W. G. Semiempirical AMI Electrostatic Potentials and AMI Electrostatic Potential Derived Charges: A Comparison with Ab Initio Values. J. Comput. Chem. 1990, 11, 159.
53. Westphal, U. Steroid-Protein Interactions II; Springer-Verlag: Berlin, 1986.
54. Dunn, J. F.; Nisula, B. C.; Rodbard, D. Transport of Steroid Hormones: Binding of 21 Endogenous Steroids to Both Testosterone-Binding Globulin and Corticosteroid-Binding Globulin in Human Plasma. J. Clin. Endocrin. Metab. 1981, 53, 58-68.
55. Mickelson, K. E.; Forsthoefel, J.; Westphal, U. Steroid Protein Interactions. Human Corticosteroid Binding Globulin: Physiochemical Properties and Binding Specificity. Biohemistry 1981, 20, 6211-6218.
56. Pugeat, M. M.; Dunn, J. F.; Nisula, B. C. Transport of Steroid Hormones: Interaction of 70 Drugs with Testosterone-Binding Globulin and Corticosteroid-Binding Globulin in Human Plasma. J. Clin. Endocrin. Metab. 1981, 53, 69-75.
57. Winn, P. J.; Lyne, P. D.; Richards, W. G. Unpublished results.